Product NDC: | 45802-736 |
Proprietary Name: | clindamycin phosphate and benzoyl peroxide |
Non Proprietary Name: | Clindamycin, Benzoyl Peroxide |
Active Ingredient(s): | 50; 10 mg/g; mg/g & nbsp; Clindamycin, Benzoyl Peroxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-736 |
Labeler Name: | Perrigo New York Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090979 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120626 |
Package NDC: | 45802-736-84 |
Package Description: | 1 TUBE in 1 CARTON (45802-736-84) > 45 g in 1 TUBE |
NDC Code | 45802-736-84 |
Proprietary Name | clindamycin phosphate and benzoyl peroxide |
Package Description | 1 TUBE in 1 CARTON (45802-736-84) > 45 g in 1 TUBE |
Product NDC | 45802-736 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Clindamycin, Benzoyl Peroxide |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 20120626 |
Marketing Category Name | ANDA |
Labeler Name | Perrigo New York Inc |
Substance Name | BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE |
Strength Number | 50; 10 |
Strength Unit | mg/g; mg/g |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [Chemical/Ingredient] |